Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women (‘Option B+’) in Malawi
Lyson Tenthani(Ministry of Health), Olivia Keiser(University of Geneva), Fabio Valeri(Institute of Social and Preventive Medicine), Andreas Jahn(University of Washington), Zengani Chirwa(University of Washington), Frank Chimbwandira(Ministry of Health), Gilles Wandeler(University of Bern), Alan Bakali, Sam Phiri(Lighthouse Trust), Hannock Tweya(University of Washington), Marcel Zwahlen(University of Bern), Andreas D. Haas(Institute of Social and Preventive Medicine), Landon Myer(University of Cape Town), Wingston Ng’ambi(University of Malawi), Joep J. van Oosterhout(Dignitas International)
Cited by 375
Related Papers
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis
|The Lancet|2007|1.4k
Cancer Risk in the Swiss HIV Cohort Study: Associations With Immunodeficiency, Smoking, and Highly Active Antiretroviral Therapy
|JNCI Journal of the National Cancer Institute|2005|857
A systematic review of the survival and complication rates of all‐ceramic and metal–ceramic reconstructions after an observation period of at least 3 years. Part II: fixed dental prostheses.
|Clinical Oral Implants Research|2007|726
Cemented and screw‐retained implant reconstructions: a systematic review of the survival and complication rates
|Clinical Oral Implants Research|2012|475